Atrium Biotechnologies Company Profile

23:22 EDT 18th March 2018 | BioPortfolio

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing segments of the health and personal care markets which are benefiting from the trend towards healthy living as well as the ageing of the population. We market a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through our highly specialized sales and marketing network, in more than 35 countries, primarily in North America, Europe and Asia.


490 Boston Post Road
United States of America


Phone: 1-866-628-2355
Fax: 1-866-866-6661

News Articles [104 Associated News Articles listed on BioPortfolio]

Atrium Hospitality Notifies Hotel Guests of Compromise

On December 8, 2017, Atrium Hospitality discovered that a workstation at the Holiday Inn Sacramento was potentially impacted by ransomware. Atrium Hospitality immediately removed Read more...

Nestle kauft für 2,3 Milliarden Dollar Atrium Innovations

FRANKFURT (Dow Jones)--Der Lebensmittelhersteller Nestle verstärkt sich im Bereich der Nahrungsergänzungsmittel. Die Schweizer vereinbarten den Kauf des kanadischen Unternehmens Atrium Innovations.....

Nestlé will für 2,3 Mrd USD kanadische Atrium Innovations übernehmen

Vevey (awp) - Der Nahrungsmittelkonzern Nestlé nimmt eine grössere Übernahme im Bereich Consumer Healthcare vor. Für einen Kaufpreis von 2,3 Mrd USD in bar will Nestlé die kanadische Atrium Innov...

Nestlé AG: Nestlé extends consumer healthcare portfolio by agreeing to acquire Atrium Innovations

This press release is also available in (Français (pdf): and (Deutsch (pd...

Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

LONDON (Reuters) - Nestle is paying $2.3 billion to buy Canadian vitamin maker Atrium Innovations, it said on Tuesday, expanding its presence in the consumer healthcare market as it seeks to offset we...

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

Elanix Biotechnologies: Erfolgreiche Studie

Transwell Biotech, ein Partner von Elanix Biotechnologies, schließt eine Phase-I Studie zur Wundbehandlung bei Hauttransplantaten ab. Das Produkt von Transwell kombiniert ein Hydrogel mit kryokonse.....

Drugs and Medications [0 Results]


PubMed Articles [96 Associated PubMed Articles listed on BioPortfolio]

Minimally Invasive Approach to Correct Anomalous Inferior Vena Cava Connection to the Left Atrium.

Anomalous drainage of the inferior vena cava into the left atrium is a rare congenital condition. A 20-year-old girl was referred for recurrent transient ischemic attacks. Transthoracic echocardiograp...

Cryoballoon ablation with left lateral decubitus position in atrial fibrillation patient where the left atrium was compressed by the vertebra.

Catheter ablation of atrial fibrillation is difficult when the left atrium is compressed by the vertebra. The heart may shift forward, and compression of the left atrium may be relieved in the left la...

Ethical principles for the use of human cellular biotechnologies.

Role of surface electrocardiogram precordial leads in localizing different anatomic sites of ectopic atrial tachycardia arising from lower right atrium in pediatric population.

The study was designed to examine P wave morphology (PWM) in precordial leads (V1 -V6 ) during ectopic atrial tachycardia (EAT) originating from low right atrium (RA) to identify the anatomic sites of...

Pilot Study to Determine Safety and Efficacy of Paclitaxel Infusion in De Novo Peripheral Lesions Using the Atrium ClearWay Balloon.

To evaluate the safety and efficacy of a one-time infusion of paclitaxel through an Atrium ClearWay balloon in infra inguinal de novo peripheral lesions.

Clinical Trials [68 Associated Clinical Trials listed on BioPortfolio]

Child With Anomalous Drainage of IVC to Left Atrium

The purpose is to see if any conclusions can be drawn about the uncommon heart defect: anomalous drainage of the inferior vena cava to the left atrium.

Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium

The aim of the study is to compare levels of differnts types of microparticles circulating before and after percutaneous occluding of the left atrium by patients with atrial fibrillation a...

Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis

This is a prospective, single center, safety and feasibility trial to evaluate the transplantation of the left atrium and pulmonary veins in patients with pulmonary vein stenosis. Consente...

Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement

This study evaluates the safety and efficiency of surgical prevention of atrial fibrillation in patients with valvular heart disease and left atrium enlargement

Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation

As the left atrium is in close vicinity to the esophagus, radiofrequency ablation in the left atrium may damage the esophagus and create esophageal perforations and esophageal left atrial ...

Companies [113 Associated Companies listed on BioPortfolio]

Atrium Biotechnologies

Atrium Biotechnologies is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. We focus primarily on growing seg...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Atrium Medical Corporation

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in ...

Æterna Zentaris Inc

The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Atrium Biotechnologies" on BioPortfolio

We have published hundreds of Atrium Biotechnologies news stories on BioPortfolio along with dozens of Atrium Biotechnologies Clinical Trials and PubMed Articles about Atrium Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atrium Biotechnologies Companies in our database. You can also find out about relevant Atrium Biotechnologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Corporate Database Quicklinks

Searches Linking to this Company Record